|
1
|
Kovesdy CP: Epidemiology of chronic kidney
disease: An update 2022. Kidney Int Suppl (2011). 12:7–11. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Flythe JE and Watnick S: Dialysis for
chronic kidney failure: A review. JAMA. 332:1559–1573. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang W, Wu X, Zhao M, Hu J, Lin C, Mei Z,
Chen J, Zhou XJ, Nie S, Nie J, et al: Kidney function and
cardiovascular disease: Evidence from observational studies and
mendelian randomization analyses. Phenomics. 4:250–253. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jha V, Al-Ghamdi SMG, Li G, Wu MS,
Stafylas P, Retat L, Card-Gowers J, Barone S, Cabrera C and Garcia
Sanchez JJ: Global economic burden associated with chronic kidney
disease: A pragmatic review of medical costs for the inside CKD
research programme. Adv Ther. 40:4405–4420. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dan Hu Q, Wang HL, Liu J, He T, Tan RZ,
Zhang Q, Su HW, Kantawong F, Lan HY and Wang L: Btg2 promotes focal
segmental glomerulosclerosis via Smad3-dependent
podocyte-mesenchymal transition. Adv Sci (Weinh). 10:e23043602023.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Panizo S, Martínez-Arias L, Alonso-Montes
C, Cannata P, Martín-Carro B, Fernández-Martín JL, Naves-Díaz M,
Carrillo-López N and Cannata-Andía JB: Fibrosis in chronic kidney
disease: Pathogenesis and consequences. Int J Mol Sci. 22:4082021.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ho HJ and Shirakawa H: Oxidative stress
and mitochondrial dysfunction in chronic kidney disease. Cells.
12:882022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kushner P, Khunti K, Cebrián A and Deed G:
Early identification and management of chronic kidney disease: A
narrative review of the crucial role of primary care practitioners.
Adv Ther. 41:3757–3770. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhu HZ, Li CY, Liu LJ, Tong JB, Lan ZH,
Tian SG, Li Q, Tong XL, Wu JF, Zhu ZG, et al: Efficacy and safety
of qingfei huatan formula in the treatment of acute exacerbation of
chronic obstructive pulmonary disease: A multi-centre, randomised,
double-blind, placebo-controlled trial. J Integr Med. 22:561–569.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Aranda-Rivera AK, Cruz-Gregorio A,
Aparicio-Trejo OE and Pedraza-Chaverri J: Mitochondrial redox
signaling and oxidative stress in kidney diseases. Biomolecules.
11:11442021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Doke T and Susztak K: The multifaceted
role of kidney tubule mitochondrial dysfunction in kidney disease
development. Trends Cell Biol. 32:841–853. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lu Y, Li Z, Zhang S, Zhang T, Liu Y and
Zhang L: Cellular mitophagy: Mechanism, roles in diseases and small
molecule pharmacological regulation. Theranostics. 13:736–766.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hoogstraten CA, Hoenderop JG and de Baaij
JHF: Mitochondrial dysfunction in kidney tubulopathies. Annu Rev
Physiol. 86:379–403. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Che R, Yuan Y, Huang S and Zhang A:
Mitochondrial dysfunction in the pathophysiology of renal diseases.
Am J Physiol Renal Physiol. 306:F367–F378. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhan M, Brooks C, Liu F, Sun L and Dong Z:
Mitochondrial dynamics: Regulatory mechanisms and emerging role in
renal pathophysiology. Kidney Int. 83:568–581. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Palorini R, De Rasmo D, Gaviraghi M, Sala
Danna L, Signorile A, Cirulli C, Chiaradonna F, Alberghina L and
Papa S: Oncogenic K-ras expression is associated with derangement
of the cAMP/PKA pathway and forskolin-reversible alterations of
mitochondrial dynamics and respiration. Oncogene. 32:352–362. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mills EL, Kelly B and O'Neill LAJ:
Mitochondria are the powerhouses of immunity. Nat Immunol.
18:488–498. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shimada K, Crother TR, Karlin J, Dagvadorj
J, Chiba N, Chen S, Ramanujan VK, Wolf AJ, Vergnes L, Ojcius DM, et
al: Oxidized mitochondrial DNA activates the NLRP3 inflammasome
during apoptosis. Immunity. 36:401–414. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Miwa S, Kashyap S, Chini E and von
Zglinicki T: Mitochondrial dysfunction in cell senescence and
aging. J Clin Invest. 132:e1584472022. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen K, Dai H, Yuan J, Chen J, Lin L,
Zhang W, Wang L, Zhang J, Li K and He Y: Optineurin-mediated
mitophagy protects renal tubular epithelial cells against
accelerated senescence in diabetic nephropathy. Cell Death Dis.
9:1052018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bhargava P and Schnellmann RG:
Mitochondrial energetics in the kidney. Nat Rev Nephrol.
13:629–646. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Holmström KM and Finkel T: Cellular
mechanisms and physiological consequences of redox-dependent
signalling. Nat Rev Mol Cell Biol. 15:411–421. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yuan Q, Tang B and Zhang C: Signaling
pathways of chronic kidney diseases, implications for therapeutics.
Signal Transduct Target Ther. 7:1822022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Podkowińska A and Formanowicz D: Chronic
kidney disease as oxidative stress- and inflammatory-mediated
cardiovascular disease. Antioxidants (Basel). 9:7522020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu X, Hussain R, Mehmood K, Tang Z, Zhang
H and Li Y: Mitochondrial-endoplasmic reticulum
communication-mediated oxidative stress and autophagy. Biomed Res
Int. 2022:64595852022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Filomeni G, De Zio D and Cecconi F:
Oxidative stress and autophagy: The clash between damage and
metabolic needs. Cell Death Differ. 22:377–388. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Quintana-Cabrera R and Scorrano L:
Determinants and outcomes of mitochondrial dynamics. Mol Cell.
83:857–876. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kühlbrandt W: Structure and function of
mitochondrial membrane protein complexes. BMC Biol. 13:892015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen W, Zhao H and Li Y: Mitochondrial
dynamics in health and disease: Mechanisms and potential targets.
Signal Transduct Target Ther. 8:3332023. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dorn GW and Kitsis RN: The mitochondrial
dynamism-mitophagy-cell death interactome: Multiple roles performed
by members of a mitochondrial molecular ensemble. Circ Res.
116:167–182. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dumesic PA, Wilensky SE, Bose S, Van
Vranken JG, Gygi SP and Spiegelman BM: RBM43 controls PGC1α
translation and a PGC1α-STING signaling axis. Cell Metab.
37:742–757 .e8. 2025.
|
|
32
|
Pernas L and Scorrano L: Mito-morphosis:
Mitochondrial fusion, fission, and cristae remodeling as key
mediators of cellular function. Annu Rev Physiol. 78:505–531. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dorn GW: Evolving concepts of
mitochondrial dynamics. Annu Rev Physiol. 81:1–17. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Garza-Lombó C, Pappa A, Panayiotidis MI
and Franco R: Redox homeostasis, oxidative stress and mitophagy.
Mitochondrion. 51:105–117. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Klionsky DJ, Petroni G, Amaravadi RK,
Baehrecke EH, Ballabio A, Boya P, Bravo-San Pedro JM, Cadwell K,
Cecconi F, Choi AMK, et al: Autophagy in major human diseases. EMBO
J. 40:e1088632021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang S, Long H, Hou L, Feng B, Ma Z, Wu Y,
Zeng Y, Cai J, Zhang DW and Zhao G: The mitophagy pathway and its
implications in human diseases. Signal Transduct Target Ther.
8:3042023. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Narendra D, Tanaka A, Suen DF and Youle
RJ: Parkin is recruited selectively to impaired mitochondria and
promotes their autophagy. J Cell Biol. 183:795–803. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Han R, Liu Y, Li S, Li XJ and Yang W:
PINK1-PRKN mediated mitophagy: Differences between in vitro and in
vivo models. Autophagy. 19:1396–1405. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Harper JW, Ordureau A and Heo JM: Building
and decoding ubiquitin chains for mitophagy. Nat Rev Mol Cell Biol.
19:93–108. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lazarou M, Sliter DA, Kane LA, Sarraf SA,
Wang C, Burman JL, Sideris DP, Fogel AI and Youle RJ: The ubiquitin
kinase PINK1 recruits autophagy receptors to induce mitophagy.
Nature. 524:309–314. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Narendra DP, Jin SM, Tanaka A, Suen DF,
Gautier CA, Shen J, Cookson MR and Youle RJ: PINK1 is selectively
stabilized on impaired mitochondria to activate parkin. PLoS Biol.
8:e10002982010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wiedemann N and Pfanner N: Mitochondrial
machineries for protein import and assembly. Annu Rev Biochem.
86:685–714. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Rasool S, Veyron S, Soya N, Eldeeb MA,
Lukacs GL, Fon EA and Trempe JF: Mechanism of PINK1 activation by
autophosphorylation and insights into assembly on the TOM complex.
Mol Cell. 82:44–59.e6. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lysyk L, Brassard R, Touret N and Lemieux
MJ: PARL protease: A glimpse at intramembrane proteolysis in the
inner mitochondrial membrane. J Mol Biol. 432:5052–5062. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yamano K and Youle RJ: PINK1 is degraded
through the N-end rule pathway. Autophagy. 9:1758–1769. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Pickrell AM and Youle RJ: The roles of
PINK1, parkin, and mitochondrial fidelity in Parkinson's disease.
Neuron. 85:257–273. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wang R, Zhu Y, Ren C, Yang S, Tian S, Chen
H, Jin M and Zhou H: Influenza A virus protein PB1-F2 impairs
innate immunity by inducing mitophagy. Autophagy. 17:496–511. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
McLelland GL, Goiran T, Yi W, Dorval G,
Chen CX, Lauinger ND, Krahn AI, Valimehr S, Rakovic A, Rouiller I,
et al: Mfn2 ubiquitination by PINK1/parkin gates the p97-dependent
release of ER from mitochondria to drive mitophagy. Elife.
7:e328662018. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Gao XY, Yang T, Gu Y and Sun XH:
Mitochondrial dysfunction in parkinson's disease: From mechanistic
insights to therapy. Front Aging Neurosci. 14:8855002022.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Yamano K, Matsuda N and Tanaka K: The
ubiquitin signal and autophagy: An orchestrated dance leading to
mitochondrial degradation. EMBO Rep. 17:300–316. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zheng X and Hunter T: Parkin mitochondrial
translocation is achieved through a novel catalytic activity
coupled mechanism. Cell Res. 23:886–897. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Malpartida AB, Williamson M, Narendra DP,
Wade-Martins R and Ryan BJ: Mitochondrial dysfunction and mitophagy
in Parkinson's disease: From mechanism to therapy. Trends Biochem
Sci. 46:329–343. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Matsuda N: Phospho-ubiquitin: Upending the
PINK-parkin-ubiquitin cascade. J Biochem. 159:379–385. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Johansen T and Lamark T: Selective
autophagy: ATG8 family proteins, LIR motifs and cargo receptors. J
Mol Biol. 432:80–103. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Deretic V and Lazarou M: A guide to
membrane atg8ylation and autophagy with reflections on immunity. J
Cell Biol. 221:e2022030832022. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Birgisdottir ÅB, Lamark T and Johansen T:
The LIR motif-crucial for selective autophagy. J Cell Sci.
126:3237–3247. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Stolz A, Ernst A and Dikic I: Cargo
recognition and trafficking in selective autophagy. Nat Cell Biol.
16:495–501. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Sun D, Wu R, Zheng J, Li P and Yu L:
Polyubiquitin chain-induced p62 phase separation drives autophagic
cargo segregation. Cell Res. 28:405–415. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Geisler S, Holmström KM, Skujat D, Fiesel
FC, Rothfuss OC, Kahle PJ and Springer W: PINK1/parkin-mediated
mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol.
12:119–131. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Deosaran E, Larsen KB, Hua R, Sargent G,
Wang Y, Kim S, Lamark T, Jauregui M, Law K, Lippincott-Schwartz J,
et al: NBR1 acts as an autophagy receptor for peroxisomes. J Cell
Sci. 126:939–952. 2013.PubMed/NCBI
|
|
61
|
Taguchi K, Fujikawa N, Komatsu M, Ishii T,
Unno M, Akaike T, Motohashi H and Yamamoto M: Keap1 degradation by
autophagy for the maintenance of redox homeostasis. Proc Natl Acad
Sci USA. 109:13561–13566. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Komatsu M, Kurokawa H, Waguri S, Taguchi
K, Kobayashi A, Ichimura Y, Sou YS, Ueno I, Sakamoto A, Tong KI, et
al: The selective autophagy substrate p62 activates the stress
responsive transcription factor Nrf2 through inactivation of Keap1.
Nat Cell Biol. 12:213–223. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Sánchez-Martín P, Sou YS, Kageyama S,
Koike M, Waguri S and Komatsu M: NBR1-mediated p62-liquid droplets
enhance the Keap1-Nrf2 system. EMBO Rep. 21:e489022020. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Qiu Y, Wang J, Li H, Yang B, Wang J, He Q
and Weng Q: Emerging views of OPTN (optineurin) function in the
autophagic process associated with disease. Autophagy. 18:73–85.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Matsumoto G, Wada K, Okuno M, Kurosawa M
and Nukina N: Serine 403 phosphorylation of p62/SQSTM1 regulates
selective autophagic clearance of ubiquitinated proteins. Mol Cell.
44:279–289. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Heo JM, Ordureau A, Paulo JA, Rinehart J
and Harper JW: The PINK1-PARKIN mitochondrial ubiquitylation
pathway drives a program of OPTN/NDP52 recruitment and TBK1
activation to promote mitophagy. Mol Cell. 60:7–20. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Yamano K and Kojima W: Molecular functions
of autophagy adaptors upon ubiquitin-driven mitophagy. Biochim
Biophys Acta Gen Subj. 1865:1299722021. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Vargas JNS, Wang C, Bunker E, Hao L, Maric
D, Schiavo G, Randow F and Youle RJ: Spatiotemporal control of ULK1
activation by NDP52 and TBK1 during selective autophagy. Mol Cell.
74:347–362.e6. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
von Muhlinen N, Akutsu M, Ravenhill BJ,
Foeglein Á, Bloor S, Rutherford TJ, Freund SM, Komander D and
Randow F: LC3C, bound selectively by a noncanonical LIR motif in
NDP52, is required for antibacterial autophagy. Mol Cell.
48:329–342. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Turco E, Savova A, Gere F, Ferrari L,
Romanov J, Schuschnig M and Martens S: Reconstitution defines the
roles of p62, NBR1 and TAX1BP1 in ubiquitin condensate formation
and autophagy initiation. Nat Commun. 12:52122021. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Ohnstad AE, Delgado JM, North BJ, Nasa I,
Kettenbach AN, Schultz SW and Shoemaker CJ: Receptor-mediated
clustering of FIP200 bypasses the role of LC3 lipidation in
autophagy. EMBO J. 39:e1049482020. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Uoselis L, Nguyen TN and Lazarou M:
Mitochondrial degradation: Mitophagy and beyond. Mol Cell.
83:3404–3420. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Field JT and Gordon JW: BNIP3 and nix:
Atypical regulators of cell fate. Biochim Biophys Acta Mol Cell
Res. 1869:1193252022. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Chen G, Ray R, Dubik D, Shi L, Cizeau J,
Bleackley RC, Saxena S, Gietz RD and Greenberg AH: The E1B
19K/Bcl-2-binding protein Nip3 is a dimeric mitochondrial protein
that activates apoptosis. J Exp Med. 186:1975–1983. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Bruick RK: Expression of the gene encoding
the proapoptotic Nip3 protein is induced by hypoxia. Proc Natl Acad
Sci USA. 97:9082–9087. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Twig G, Elorza A, Molina AJ, Mohamed H,
Wikstrom JD, Walzer G, Stiles L, Haigh SE, Katz S, Las G, et al:
Fission and selective fusion govern mitochondrial segregation and
elimination by autophagy. EMBO J. 27:433–446. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Zhang T, Xue L, Li L, Tang C, Wan Z, Wang
R, Tan J, Tan Y, Han H, Tian R, et al: BNIP3 protein suppresses
PINK1 kinase proteolytic cleavage to promote mitophagy. J Biol
Chem. 291:21616–21629. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Lee Y, Lee HY, Hanna RA and Gustafsson ÅB:
Mitochondrial autophagy by Bnip3 involves Drp1-mediated
mitochondrial fission and recruitment of parkin in cardiac
myocytes. Am J Physiol Heart Circ Physiol. 301:H1924–H1931. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Marinković M, Šprung M and Novak I:
Dimerization of mitophagy receptor BNIP3L/NIX is essential for
recruitment of autophagic machinery. Autophagy. 17:1232–1243. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Sandoval H, Thiagarajan P, Dasgupta SK,
Schumacher A, Prchal JT, Chen M and Wang J: Essential role for nix
in autophagic maturation of erythroid cells. Nature. 454:232–235.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Xiang G, Yang L, Long Q, Chen K, Tang H,
Wu Y, Liu Z, Zhou Y, Qi J, Zheng L, et al: BNIP3L-dependent
mitophagy accounts for mitochondrial clearance during 3
factors-induced somatic cell reprogramming. Autophagy.
13:1543–1555. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Esteban-Martínez L and Boya P:
BNIP3L/NIX-dependent mitophagy regulates cell differentiation via
metabolic reprogramming. Autophagy. 14:915–917. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Melser S, Chatelain EH, Lavie J, Mahfouf
W, Jose C, Obre E, Goorden S, Priault M, Elgersma Y, Rezvani HR, et
al: Rheb regulates mitophagy induced by mitochondrial energetic
status. Cell Metab. 17:719–730. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Gao F, Chen D, Si J, Hu Q, Qin Z, Fang M
and Wang G: The mitochondrial protein BNIP3L is the substrate of
PARK2 and mediates mitophagy in PINK1/PARK2 pathway. Hum Mol Genet.
24:2528–2538. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Cao Y, Zheng J, Wan H, Sun Y, Fu S, Liu S,
He B, Cai G, Cao Y, Huang H, et al: A mitochondrial SCF-FBXL4
ubiquitin E3 ligase complex degrades BNIP3 and NIX to restrain
mitophagy and prevent mitochondrial disease. EMBO J.
42:e1130332023. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Zhu Y, Massen S, Terenzio M, Lang V,
Chen-Lindner S, Eils R, Novak I, Dikic I, Hamacher-Brady A and
Brady NR: Modulation of serines 17 and 24 in the LC3-interacting
region of Bnip3 determines pro-survival mitophagy versus apoptosis.
J Biol Chem. 288:1099–1113. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Rogov VV, Suzuki H, Marinković M, Lang V,
Kato R, Kawasaki M, Buljubašić M, Šprung M, Rogova N, Wakatsuki S,
et al: Phosphorylation of the mitochondrial autophagy receptor nix
enhances its interaction with LC3 proteins. Sci Rep. 7:11312017.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Clague MJ and Urbé S: Diverse routes to
mitophagy governed by ubiquitylation and mitochondrial import.
Trends Cell Biol. 35:527–538. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Zhang W: The mitophagy receptor FUN14
domain-containing 1 (FUNDC1): A promising biomarker and potential
therapeutic target of human diseases. Genes Dis. 8:640–654. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Liu L, Feng D, Chen G, Chen M, Zheng Q,
Song P, Ma Q, Zhu C, Wang R, Qi W, et al: Mitochondrial
outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in
mammalian cells. Nat Cell Biol. 14:177–185. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Kuang Y, Ma K, Zhou C, Ding P, Zhu Y, Chen
Q and Xia B: Structural basis for the phosphorylation of FUNDC1 LIR
as a molecular switch of mitophagy. Autophagy. 12:2363–2373. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Zhou H, Zhu P, Wang J, Zhu H, Ren J and
Chen Y: Pathogenesis of cardiac ischemia reperfusion injury is
associated with CK2α-disturbed mitochondrial homeostasis via
suppression of FUNDC1-related mitophagy. Cell Death Differ.
25:1080–1093. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Chen G, Han Z, Feng D, Chen Y, Chen L, Wu
H, Huang L, Zhou C, Cai X, Fu C, et al: A regulatory signaling loop
comprising the PGAM5 phosphatase and CK2 controls receptor-mediated
mitophagy. Mol Cell. 54:362–377. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Wu W, Tian W, Hu Z, Chen G, Huang L, Li W,
Zhang X, Xue P, Zhou C, Liu L, et al: ULK1 translocates to
mitochondria and phosphorylates FUNDC1 to regulate mitophagy. EMBO
Rep. 15:566–575. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Tang C, Livingston MJ, Liu Z and Dong Z:
Autophagy in kidney homeostasis and disease. Nat Rev Nephrol.
16:489–508. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Wullschleger S, Loewith R and Hall MN: TOR
signaling in growth and metabolism. Cell. 124:471–484. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Hosokawa N, Hara T, Kaizuka T, Kishi C,
Takamura A, Miura Y, Iemura S, Natsume T, Takehana K, Yamada N, et
al: Nutrient-dependent mTORC1 association with the
ULK1-Atg13-FIP200 complex required for autophagy. Mol Biol Cell.
20:1981–1991. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Herzig S and Shaw RJ: AMPK: Guardian of
metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol.
19:121–135. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Kim J, Kundu M, Viollet B and Guan KL:
AMPK and mTOR regulate autophagy through direct phosphorylation of
Ulk1. Nat Cell Biol. 13:132–141. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Perico L, Remuzzi G and Benigni A:
Sirtuins in kidney health and disease. Nat Rev Nephrol. 20:313–329.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Liu S, Liu Y, Li J, Wang M, Chen X, Gan F,
Wen L, Huang K and Liu D: Arsenic exposure-induced acute kidney
injury by regulating SIRT1/PINK1/mitophagy axis in mice and in HK-2
cells. J Agric Food Chem. 71:15809–15820. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Liu T, Yang Q, Zhang X, Qin R, Shan W,
Zhang H and Chen X: Quercetin alleviates kidney fibrosis by
reducing renal tubular epithelial cell senescence through the
SIRT1/PINK1/mitophagy axis. Life Sci. 257:1181162020. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Jin L, Galonek H, Israelian K, Choy W,
Morrison M, Xia Y, Wang X, Xu Y, Yang Y, Smith JJ, et al:
Biochemical characterization, localization, and tissue distribution
of the longer form of mouse SIRT3. Protein Sci. 18:514–525. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Xu S, Gao Y, Zhang Q, Wei S, Chen Z, Dai
X, Zeng Z and Zhao KS: SIRT1/3 activation by resveratrol attenuates
acute kidney injury in a septic rat model. Oxid Med Cell Longev.
2016:72960922016. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Deng Z, He M, Hu H, Zhang W, Zhang Y, Ge
Y, Ma T, Wu J, Li L, Sun M, et al: Melatonin attenuates
sepsis-induced acute kidney injury by promoting mitophagy through
SIRT3-mediated TFAM deacetylation. Autophagy. 20:151–165. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Polletta L, Vernucci E, Carnevale I,
Arcangeli T, Rotili D, Palmerio S, Steegborn C, Nowak T,
Schutkowski M, Pellegrini L, et al: SIRT5 regulation of
ammonia-induced autophagy and mitophagy. Autophagy. 11:253–270.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Cui X, Zhou Z, Tu H, Wu J, Zhou J, Yi Q,
Liu O and Dai X: Mitophagy in fibrotic diseases: Molecular
mechanisms and therapeutic applications. Front Physiol.
15:14302302024. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Liu BC, Tang TT, Lv LL and Lan HY: Renal
tubule injury: A driving force toward chronic kidney disease.
Kidney Int. 93:568–579. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Ohashi R, Shimizu A, Masuda Y, Kitamura H,
Ishizaki M, Sugisaki Y and Yamanaka N: Peritubular capillary
regression during the progression of experimental obstructive
nephropathy. J Am Soc Nephrol. 13:1795–1805. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Li S, Lin Q, Shao X, Zhu X, Wu J, Wu B,
Zhang M, Zhou W, Zhou Y, Jin H, et al: Drp1-regulated
PARK2-dependent mitophagy protects against renal fibrosis in
unilateral ureteral obstruction. Free Radic Biol Med. 152:632–649.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Bhatia D, Chung KP, Nakahira K, Patino E,
Rice MC, Torres LK, Muthukumar T, Choi AM, Akchurin OM and Choi ME:
Mitophagy-dependent macrophage reprogramming protects against
kidney fibrosis. JCI Insight. 4:e1328261328262019. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Chawla LS, Eggers PW, Star RA and Kimmel
PL: Acute kidney injury and chronic kidney disease as
interconnected syndromes. N Engl J Med. 371:58–66. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Venkatachalam MA, Weinberg JM, Kriz W and
Bidani AK: Failed tubule recovery, AKI-CKD transition, and kidney
disease progression. J Am Soc Nephrol. 26:1765–1776. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Pavlović N, Križanac M, Kumrić M,
Vukojević K and Božić J: Mitochondrial dysfunction: The silent
catalyst of kidney disease progression. Cells. 14:7942025.
View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Bhat ZY, Cadnapaphornchai P, Ginsburg K,
Sivagnanam M, Chopra S, Treadway CK, Lin HS, Yoo G, Sukari A and
Doshi MD: Understanding the risk factors and long-term consequences
of cisplatin-associated acute kidney injury: An observational
cohort study. PLoS One. 10:e01422252015. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Mapuskar KA, Wen H, Holanda DG, Rastogi P,
Steinbach E, Han R, Coleman MC, Attanasio M, Riley DP, Spitz DR, et
al: Persistent increase in mitochondrial superoxide mediates
cisplatin-induced chronic kidney disease. Redox Biol. 20:98–106.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Zhao C, Chen Z, Xu X, An X, Duan S, Huang
Z, Zhang C, Wu L, Zhang B, Zhang A, et al: Pink1/Parkin-mediated
mitophagy play a protective role in cisplatin induced renal tubular
epithelial cells injury. Exp Cell Res. 350:390–397. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Ludwig-Portugall I, Bartok E, Dhana E,
Evers BD, Primiano MJ, Hall JP, Franklin BS, Knolle PA, Hornung V,
Hartmann G, et al: An NLRP3-specific inflammasome inhibitor
attenuates crystal-induced kidney fibrosis in mice. Kidney Int.
90:525–539. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Li J, Lin Q, Shao X, Li S, Zhu X, Wu J,
Mou S, Gu L, Wang Q, Zhang M, et al: HIF1α-BNIP3-mediated mitophagy
protects against renal fibrosis by decreasing ROS and inhibiting
activation of the NLRP3 inflammasome. Cell Death Dis. 14:2002023.
View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Huang Y and Yang L: Regulation of
pyroptosis and ferroptosis by mitophagy in chronic kidney disease.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 49:1769–1776. 2024.(In
English, Chinese). PubMed/NCBI
|
|
121
|
Guo J, Yuan Z and Wang R: Zn2+
improves sepsis-induced acute kidney injury by upregulating
SIRT7-mediated parkin acetylation. Am J Physiol Renal Physiol.
327:F184–F197. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Fu ZJ, Wang ZY, Xu L, Chen XH, Li XX, Liao
WT, Ma HK, Jiang MD, Xu TT, Xu J, et al: HIF-1α-BNIP3-mediated
mitophagy in tubular cells protects against renal
ischemia/reperfusion injury. Redox Biol. 36:1016712020. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Zhou L, Zhang L, Zhang Y, Yu X, Sun X, Zhu
T, Li X, Liang W, Han Y and Qin C: PINK1 deficiency ameliorates
cisplatin-induced acute kidney injury in rats. Front Physiol.
10:12252019. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Li K, Xia X and Tong Y: Multiple roles of
mitochondrial autophagy receptor FUNDC1 in mitochondrial events and
kidney disease. Front Cell Dev Biol. 12:14533652024. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Bi Y, Liu S, Qin X, Abudureyimu M, Wang L,
Zou R, Ajoolabady A, Zhang W, Peng H, Ren J and Zhang Y: FUNDC1
interacts with GPx4 to govern hepatic ferroptosis and fibrotic
injury through a mitophagy-dependent manner. J Adv Res. 55:45–60.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Sies H and Cadenas E: Oxidative stress:
Damage to intact cells and organs. Philos Trans R Soc Lond B Biol
Sci. 311:617–631. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Sies H, Berndt C and Jones DP: Oxidative
stress. Annu Rev Biochem. 86:715–748. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Forman HJ and Zhang H: Targeting oxidative
stress in disease: Promise and limitations of antioxidant therapy.
Nat Rev Drug Discov. 20:689–709. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Modlinger PS, Wilcox CS and Aslam S:
Nitric oxide, oxidative stress, and progression of chronic renal
failure. Semin Nephrol. 24:354–365. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Murphy MP: How mitochondria produce
reactive oxygen species. Biochem J. 417:1–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Zorov DB, Juhaszova M and Sollott SJ:
Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS
release. Physiol Rev. 94:909–950. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Sies H and Jones DP: Reactive oxygen
species (ROS) as pleiotropic physiological signalling agents. Nat
Rev Mol Cell Biol. 21:363–383. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Sureshbabu A, Ryter SW and Choi ME:
Oxidative stress and autophagy: Crucial modulators of kidney
injury. Redox Biol. 4:208–214. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Sedeek M, Nasrallah R, Touyz RM and Hébert
RL: NADPH oxidases, reactive oxygen species, and the kidney: Friend
and foe. J Am Soc Nephrol. 24:1512–1518. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Leung JCK, Chan LYY, Tang SCW, Lam MF,
Chow CW, Lim AI and Lai KN: Oxidative damages in tubular epithelial
cells in IgA nephropathy: Role of crosstalk between angiotensin II
and aldosterone. J Transl Med. 9:1692011. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Ursini F, Maiorino M and Forman HJ: Redox
homeostasis: The golden mean of healthy living. Redox Biol.
8:205–215. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Ruiz S, Pergola PE, Zager RA and Vaziri
ND: Targeting the transcription factor Nrf2 to ameliorate oxidative
stress and inflammation in chronic kidney disease. Kidney Int.
83:1029–1041. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Yamamoto M, Kensler TW and Motohashi H:
The KEAP1-NRF2 system: A thiol-based sensor-effector apparatus for
maintaining redox homeostasis. Physiol Rev. 98:1169–1203. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Wakabayashi N, Dinkova-Kostova AT,
Holtzclaw WD, Kang MI, Kobayashi A, Yamamoto M, Kensler TW and
Talalay P: Protection against electrophile and oxidant stress by
induction of the phase 2 response: Fate of cysteines of the Keap1
sensor modified by inducers. Proc Natl Acad Sci USA. 101:2040–2045.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Sykiotis GP and Bohmann D:
Stress-activated Cap'n'collar transcription factors in aging and
human disease. Sci Signal. 3:re32010. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Tretter V, Hochreiter B, Zach ML, Krenn K
and Klein KU: Understanding cellular redox homeostasis: A challenge
for precision medicine. Int J Mol Sci. 23:1062021. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Oyewole AO and Birch-Machin MA:
Mitochondria-targeted antioxidants. FASEB J. 29:4766–4771. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Kataura T, Otten EG, Rabanal-Ruiz Y,
Adriaenssens E, Urselli F, Scialo F, Fan L, Smith GR, Dawson WM,
Chen X, et al: NDP52 acts as a redox sensor in
PINK1/parkin-mediated mitophagy. EMBO J. 42:e1113722023. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Hsu SN, Stephen LA, Phadwal K, Dillon S,
Carter R, Morton NM, Luijten I, Emelianova K, Amin AK, Macrae VE,
et al: Mitochondrial dysfunction and mitophagy blockade contribute
to renal osteodystrophy in chronic kidney disease-mineral bone
disorder. Kidney Int. 107:1017–1036. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Xu D, Chen P, Wang B, Wang Y, Miao N, Yin
F, Cheng Q, Zhou Z, Xie H, Zhou L, et al: NIX-mediated mitophagy
protects against proteinuria-induced tubular cell apoptosis and
renal injury. Am J Physiol Renal Physiol. 316:F382–F395. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Wei X, Wang Y, Lao Y, Weng J, Deng R, Li
S, Lu J, Yang S and Liu X: Effects of honokiol protects against
chronic kidney disease via BNIP3/NIX and FUNDC1-mediated mitophagy
and AMPK pathways. Mol Biol Rep. 50:6557–6568. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Yang K, Li T, Geng Y, Zou X, Peng F and
Gao W: The role of mitophagy in the development of chronic kidney
disease. PeerJ. 12:e172602024. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Reyes-Fermín LM, Avila-Rojas SH,
Aparicio-Trejo OE, Tapia E, Rivero I and Pedraza-Chaverri J: The
protective effect of alpha-mangostin against cisplatin-induced cell
death in LLC-PK1 cells is associated to mitochondrial function
preservation. Antioxidants (Basel). 8:1332019. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Prieto-Carrasco R, García-Arroyo FE,
Aparicio-Trejo OE, Rojas-Morales P, León-Contreras JC,
Hernández-Pando R, Sánchez-Lozada LG, Tapia E and Pedraza-Chaverri
J: Progressive reduction in mitochondrial mass is triggered by
alterations in mitochondrial biogenesis and dynamics in chronic
kidney disease induced by 5/6 nephrectomy. Biology (Basel).
10:3492021.PubMed/NCBI
|
|
150
|
Wen CP, Cheng TYD, Tsai MK, Chang YC, Chan
HT, Tsai SP, Chiang PH, Hsu CC, Sung PK, Hsu YH and Wen SF:
All-cause mortality attributable to chronic kidney disease: A
prospective cohort study based on 462 293 adults in taiwan. Lancet.
371:2173–2182. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Dwivedi S and Sikarwar MS: Diabetic
nephropathy: Pathogenesis, mechanisms, and therapeutic strategies.
Horm Metab Res. 57:7–17. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Han YC, Tang SQ, Liu YT, Li AM, Zhan M,
Yang M, Song N, Zhang W, Wu XQ, Peng CH, et al: AMPK agonist
alleviate renal tubulointerstitial fibrosis via activating
mitophagy in high fat and streptozotocin induced diabetic mice.
Cell Death Dis. 12:9252021. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Czajka A, Ajaz S, Gnudi L, Parsade CK,
Jones P, Reid F and Malik AN: Altered mitochondrial function,
mitochondrial DNA and reduced metabolic flexibility in patients
with diabetic nephropathy. EBioMedicine. 2:499–512. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Holterman CE, Thibodeau JF, Towaij C,
Gutsol A, Montezano AC, Parks RJ, Cooper ME, Touyz RM and Kennedy
CR: Nephropathy and elevated BP in mice with podocyte-specific
NADPH oxidase 5 expression. J Am Soc Nephrol. 25:784–797. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Sang XY, Xiao JJ, Liu Q, Zhu R, Dai JJ,
Zhang C, Yu H, Yang SJ and Zhang BF: Regulators of calcineurin 1
deficiency attenuates tubulointerstitial fibrosis through improving
mitochondrial fitness. FASEB J. doi: 10.1096/fj.202000781RRR.
|
|
156
|
Li Y, Song B, Ruan C, Xue W and Zhao J:
AdipoRon attenuates hypertension-induced epithelial-mesenchymal
transition and renal fibrosis via promoting epithelial autophagy. J
Cardiovasc Transl Res. 14:538–545. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Long Y, Li Y, Ma Z, Xie Y, Zhao H, Zhang M
and Liu R: Epimedii folium and ligustri lucidi fructus
synergistically delay renal aging through
AMPK/ULK1/Bcl2L13-mediated mitophagy. J Ethnopharmacol.
346:1196682025. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Wang Y, Ma Y, Ke Y, Jiang X, Liu J, Xiao
Y, Zheng H, Wang C, Chen X and Shi M: Fangji huangqi
decoction ameliorates membranous nephropathy through the
upregulation of BNIP3-mediated mitophagy. J Ethnopharmacol.
324:1177342024. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Wang H, Shen M, Ma Y, Lan L, Jiang X, Cen
X, Guo G, Zhou Q, Yuan M, Chen J, et al: Novel mitophagy inducer
alleviates lupus nephritis by reducing myeloid cell activation and
autoantigen presentation. Kidney Int. 105:759–774. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Wang Y, Lu M, Xiong L, Fan J, Zhou Y, Li
H, Peng X, Zhong Z, Wang Y, Huang F, et al: Drp1-mediated
mitochondrial fission promotes renal fibroblast activation and
fibrogenesis. Cell Death Dis. 11:292020. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Dröge W: Free radicals in the
physiological control of cell function. Physiol Rev. 82:47–95.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Dounousi E, Papavasiliou E, Makedou A,
Ioannou K, Katopodis KP, Tselepis A, Siamopoulos KC and Tsakiris D:
Oxidative stress is progressively enhanced with advancing stages of
CKD. Am J Kidney Dis. 48:752–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Zhang L, Miao M, Xu X, Bai M, Wu M and
Zhang A: From physiology to pathology: The role of mitochondria in
acute kidney injuries and chronic kidney diseases. Kidney Dis
(Basel). 9:342–357. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Cheng Y, Lu Z, Mao T, Song Y, Qu Y, Chen
X, Chen K, Liu K and Zhang C: Magnoflorine ameliorates chronic
kidney disease in high-fat and high-fructose-fed mice by promoting
parkin/PINK1-dependent mitophagy to inhibit
NLRP3/caspase-1-mediated pyroptosis. J Agric Food Chem.
72:12775–12787. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Li H, Meng P, Meng Y, Yang Y, Zheng W,
Huang H and Zhao Z: Mechanism of ruxolitinib enhancing mitophagy
against renal fibrosis via PINK1/parkin pathway. Biochim Biophys
Acta Mol Basis Dis. 1871:1679782025. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Ding XQ, Jian TY, Gai YN, Niu GT, Liu Y,
Meng XH, Li J, Lyu H, Ren BR and Chen J: Chicoric acid attenuated
renal tubular injury in HFD-induced chronic kidney disease mice
through the promotion of mitophagy via the Nrf2/PINK/parkin
pathway. J Agric Food Chem. 70:2923–2935. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Cao Y, Xiong J, Guan X, Yin S, Chen J,
Yuan S, Liu H, Lin S, Zhou Y, Qiu J, et al: Paeoniflorin suppresses
kidney inflammation by regulating macrophage polarization via
KLF4-mediated mitophagy. Phytomedicine. 116:1549012023. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Jia Q, Han L, Zhang X, Yang W, Gao Y, Shen
Y, Li B, Wang S, Qin M, Lowe S, et al: Tongluo yishen decoction
ameliorates renal fibrosis via regulating mitochondrial dysfunction
induced by oxidative stress in unilateral ureteral obstruction
rats. Front Pharmacol. 12:7627562021. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Ren H, Shao Y, Wu C, Ma X, Lv C and Wang
Q: Metformin alleviates oxidative stress and enhances autophagy in
diabetic kidney disease via AMPK/SIRT1-FoxO1 pathway. Mol Cell
Endocrinol. 500:1106282020. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Hong Q, Zhang L, Das B, Li Z, Liu B, Cai
G, Chen X, Chuang PY, He JC and Lee K: Increased podocyte sirtuin-1
function attenuates diabetic kidney injury. Kidney Int.
93:1330–1343. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Galluzzi L, Bravo-San Pedro JM, Levine B,
Green DR and Kroemer G: Pharmacological modulation of autophagy:
Therapeutic potential and persisting obstacles. Nat Rev Drug
Discov. 16:487–511. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Bonekamp NA, Jiang M, Motori E, Garcia
Villegas R, Koolmeister C, Atanassov I, Mesaros A, Park CB and
Larsson NG: High levels of TFAM repress mammalian mitochondrial DNA
transcription in vivo. Life Sci Alliance. 4:e2021010342021.
View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Wang R, Yuan W, Li L, Lu F, Zhang L, Gong
H and Huang X: Resveratrol ameliorates muscle atrophy in chronic
kidney disease via the axis of SIRT1/FoxO1. Phytother Res.
36:3265–3275. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Zhang W, Guo C, Li Y, Wang H, Wang H, Wang
Y, Wu T, Wang H, Cheng G, Man J, et al: Mitophagy mediated by
HIF-1α/FUNDC1 signaling in tubular cells protects against renal
ischemia/reperfusion injury. Ren Fail. 46:23324922024. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Sharma GN, Gupta G and Sharma P: A
comprehensive review of free radicals, antioxidants, and their
relationship with human ailments. Crit Rev Eukaryot Gene Expr.
28:139–154. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Harden TK, Sesma JI, Fricks IP and
Lazarowski ER: Signalling and pharmacological properties of the P2Y
receptor. Acta Physiol (Oxf). 199:149–160. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Bai X, Huang D, Xie P, Sun R, Zhou H and
Liu Y: Effect of uridine on mitochondrial function. Sheng Wu Gong
Cheng Xue Bao. 39:3695–3709. 2023.(In Chinese). PubMed/NCBI
|
|
178
|
Krylova IB, Selina EN, Bulion VV,
Rodionova OM, Evdokimova NR, Belosludtseva NV, Shigaeva MI and
Mironova GD: Uridine treatment prevents myocardial injury in rat
models of acute ischemia and ischemia/reperfusion by activating the
mitochondrial ATP-dependent potassium channel. Sci Rep.
11:169992021. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Jiang N and Zhao Z: Intestinal aging is
alleviated by uridine via regulating inflammation and oxidative
stress in vivo and in vitro. Cell Cycle. 21:1519–1531. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Wang Y, Ping Z, Gao H, Liu Z, Xv Q, Jiang
X and Yu W: LYC inhibits the AKT signaling pathway to activate
autophagy and ameliorate TGFB-induced renal fibrosis. Autophagy.
20:1114–1133. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Smith RAJ, Hartley RC and Murphy MP:
Mitochondria-targeted small molecule therapeutics and probes.
Antioxid Redox Signal. 15:3021–3038. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Kelso GF, Porteous CM, Coulter CV, Hughes
G, Porteous WK, Ledgerwood EC, Smith RA and Murphy MP: Selective
targeting of a redox-active ubiquinone to mitochondria within
cells: Antioxidant and antiapoptotic properties. J Biol Chem.
276:4588–4596. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
183
|
James AM, Cochemé HM, Smith RAJ and Murphy
MP: Interactions of mitochondria-targeted and untargeted
ubiquinones with the mitochondrial respiratory chain and reactive
oxygen species. Implications for the use of exogenous ubiquinones
as therapies and experimental tools. J Biol Chem. 280:21295–21312.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Hamed M, Logan A, Gruszczyk AV, Beach TE,
James AM, Dare AJ, Barlow A, Martin J, Georgakopoulos N, Gane AM,
et al: Mitochondria-targeted antioxidant MitoQ ameliorates
ischaemia-reperfusion injury in kidney transplantation models. Br J
Surg. 108:1072–1081. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Zhu Z, Liang W, Chen Z, Hu J, Feng J, Cao
Y, Ma Y and Ding G: Mitoquinone protects podocytes from angiotensin
II-induced mitochondrial dysfunction and injury via the Keap1-Nrf2
signaling pathway. Oxid Med Cell Longev. 2021:13944862021.
View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Reddy PH, Manczak M and Kandimalla R:
Mitochondria-targeted small molecule SS31: A potential candidate
for the treatment of Alzheimer's disease. Hum Mol Genet.
26:15972017. View Article : Google Scholar : PubMed/NCBI
|
|
187
|
Hou Y, Li S, Wu M, Wei J, Ren Y, Du C, Wu
H, Han C, Duan H and Shi Y: Mitochondria-targeted peptide SS-31
attenuates renal injury via an antioxidant effect in diabetic
nephropathy. Am J Physiol Renal Physiol. 310:F547–F559. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
188
|
Yang SK, Han YC, He JR, Yang M, Zhang W,
Zhan M, Li AM, Li L, Na-Song, Liu YT, et al: Mitochondria targeted
peptide SS-31 prevent on cisplatin-induced acute kidney injury via
regulating mitochondrial ROS-NLRP3 pathway. Biomed Pharmacother.
130:1105212020. View Article : Google Scholar : PubMed/NCBI
|
|
189
|
Zhu Y, Luo M, Bai X, Li J, Nie P, Li B and
Luo P: SS-31, a mitochondria-targeting peptide, ameliorates kidney
disease. Oxid Med Cell Longev. 2022:12955092022. View Article : Google Scholar : PubMed/NCBI
|
|
190
|
Lan T, Guo H, Lu X, Geng K, Wu L, Luo Y,
Zhu J, Shen X, Guo Q and Wu S: Dual-responsive curcumin-loaded
nanoparticles for the treatment of cisplatin-induced acute kidney
injury. Biomacromolecules. 23:5253–5266. 2022. View Article : Google Scholar : PubMed/NCBI
|
